Index
Checking point of information
at the time of initial public offering.
AI Analysis
■AI Analysis
AI statistically analyzes IPO information to identify trends.
The closer the number is to 5, the higher the rate of increase in the initial price relative to the offering price.
| popularity | scale-criteria | offering-criteria | exchange-criteria | market-condition | Business-criteria |
| 3 | 1 | 5 | 5 | 4 | 1 |
*This is an analysis of trends and does not guarantee any results.
This is not a solicitation to buy or sell stocks, nor is it investment advice.
*Please check the disclaimer for details.
■AI Analysis Chart
A group of stocks listed in the past
with similar IPO condition trends
| Name | Rate of change
(Inicial Price) |
|
| -15.0% |
|
| +60.0% |
|
| +22.5% |
|
| +77.6% |
|
| +63.9% |
|
| +151.6% |
CompanyOverview
- Company Name：Noile-Immune Biotech Inc
- Business：CAR-T細胞療法を主とした新規がん免疫療法の開発.
- The industry sector is Pharmaceutical.
- Scheduled to be listed on TSE-Growth.
- The company size is that assumed market capitalization is
approx. 293 Million JPY (excluded public offering), approx. 320 Million JPY (included public offering).
- The lead manager is ＳＭＢＣ日興.
https://www.noile-immune.com/
Initial Public Offering Memo
■ Market Cap | Offering rate | Dilution rate | lock-up information
- The company size is assumed market capitalization is
approx. 293 Million JPY (excluded new issues), approx. 320 Million JPY (included new issues).
- The total amount of new issues is 26.8 Million JPY.
- The total amount of public offering is 4.0 Million JPY.
- The dilution ratio from the new issues is 9%.
- Rate of offering is aprrox. 1%.
- The number of outstanding shares is 39,579,865 shares (excluded new issues),
43,202,865 shares (included new issues).
- The number of diluted shares for stock acquisition rights is 2,842,000 shares.
- Date of 180-day lockup release (initially scheduled) is December 24, 2023.
■ Book building schedule | Payment schedule
- Book building Period *1：June 13, 2023(Tue.) - June 16, 2023(Fri.)
- Priced date *2 ：June 19, 2023(Mon.)
- Payment Period *3 ：June 20, 2023(Tue.) - June 23, 2023(Fri.)
- Listing Date ：June 28, 2023(wed.)
*1:(Period for applying lottery to obtain the right to purchase)
*2:(The date when the purchase price is determined)
*3:(Period for expressing your intent to purchase and payment,if you are selected in the lottery)
■ Detail of new issue or public offering
- Unit of application：100 shares (Minimum deposit amount is 74,000 JPY.)
- Assumed issue price：720 JPY
- Tentatively price range：700 JPY - 740 JPY
- Public offering price：740 JPY
- The initial price on listed：695 JPY(-6.1％)
- Newly Issued Shares：3,623,000 shares (Domestic：1,019,000 shares ＋ Overseas：2,604,000 shares)
- Public offering shares：543,400 shares (Domestic：543,400 shares ＋ Overseas：0 shares)
- Number of domestic unit：15,624 Unit
- The lead manager is ＳＭＢＣ日興証券.
- The another securities companies are ＳＢＩ証券/野村證券/みずほ証券/東洋証券/岩井コスモ証券/あかつき証券/丸三証券/極東証券/マネックス証券/岡三証券.
| ＳＭＢＣ日興 |
ＳＢＩ |
野村 |
みずほ |
東洋 |
岩井コスモ |
あかつき |
丸三 |
極東 |
マネックス |
岡三 |
| Lead |
Sub |
Sub |
Sub |
Sub |
Sub |
Sub |
Sub |
Sub |
Sub |
Sub |
■ New issue or public offering - condition history
|
Update
date |
Assumed issue
price
(JPY) |
Tentatively
price range
(JPY) |
Public offering
price
(JPY) |
| Initial | 2023-05-25 | 720 JPY | | |
| Application period | 2023-06-12 | | 700 - 740 JPY | |
| Priced | 2023-06-19 | | | 740 JPY |
|
Update
date |
New issues
total shares |
New issues
(Overseas) |
PO&OA
total shares |
PO
(Domestic) |
PO
(Overseas) |
OA
(Domestic) |
OA
(Overseas) |
| Initial | 2023-05-25 | 3,623,000 | 2,083,200 | 543,400 | 0 | 0 | 543,400 | 0 |
| Application period | 2023-06-12 | 3,623,000 | 2,083,200 | 543,400 | 0 | 0 | 543,400 | 0 |
| Priced | 2023-06-19 | 3,623,000 | 2,604,000 | 543,400 | 0 | 0 | 543,400 | 0 |
※：( ) indicates the breakdown.
e.g. In the case of a PO(overseas), there are domestic and overseas allotments of the public offering, of which the overseas allotment is indicated.
PO : Public offering OA : Over allotment
